Clinical Trial Update: A Study of Aprepitant (MK-0869) in Pediatric Participants Undergoing Surgery (MK-0869-148) [Phase 1]

View source ↗

Summary

Phase 1 study of aprepitant (MK-0869) in pediatric patients undergoing surgery for postoperative nausea and vomiting has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting

Drugs mentioned

• Aprepitant (aprepitant)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Postoperative Nausea and Vomiting | Phase 1 | Status: COMPLETED | Results posted: 2014-02-14